Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report)'s stock price was up 6.3% on Tuesday . The company traded as high as $10.78 and last traded at $10.70. Approximately 5,079,647 shares changed hands during mid-day trading, an increase of 1,403% from the average daily volume of 337,931 shares. The stock had previously closed at $10.07.
Silverback Therapeutics Stock Down 1.2%
The business has a 50-day simple moving average of $15.38 and a two-hundred day simple moving average of $14.37. The stock has a market capitalization of $361.66 million, a P/E ratio of -4.14 and a beta of 0.60.
About Silverback Therapeutics
(
Get Free Report)
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Further Reading
Before you consider Silverback Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.
While Silverback Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
